Ministry of Health Malaysia. Malaysian rare disease list. Genetic/rare disease: portal rasmi kementerian kesihatan Malaysia. Putrajaya: Ministry of Health Malaysia. https://www.moh.gov.my/index.php/pages/view/3774. Last Updated March 2023. Last accessed 4/1/2025.
2.
KavitaAAbdul OnnyMASuppiahS, et al.A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - a case report. Med J Malaysia2021; 76(5): 762–767.
3.
AliasAMRaja ShariffRESaidonN, et al.Cardiac amyloidosis: everywhere, but nowhere. J Asian Pac Soc Cardiol2024; 3: e05.
Writing CommitteeKittlesonMMRubergFLAmbardekarAV, et al.2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol2023; 81(11): 1076–1126.
6.
BartNKFatkinDGuntonJ, et al.2024 Australia-New Zealand expert consensus statement on cardiac amyloidosis. Heart Lung Circ2024; 33(4): 420–442.
7.
LeeTHWangYFHuLH, et al.Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis. Jpn J Radiol2023; 41(8): 882–888.
FontanaMSolomonSDKachadourianJ, et al.CRISPR-Cas9 gene editing with nexiguran ziclumeran for ATTR cardiomyopathy. N Engl J Med2024; 391(23): 2231–2241.
